Advertisement
UK markets close in 8 hours 11 minutes

  • FTSE 100

    8,129.60
    +50.74 (+0.63%)
     

  • FTSE 250

    19,667.09
    +65.11 (+0.33%)
     

  • AIM

    754.58
    +1.46 (+0.19%)
     

  • GBP/EUR

    1.1652
    -0.0005 (-0.04%)
     

  • GBP/USD

    1.2503
    -0.0008 (-0.06%)
     

  • Bitcoin GBP

    51,432.39
    -49.64 (-0.10%)
     

  • CMC Crypto 200

    1,388.37
    -8.16 (-0.58%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.14
    +0.57 (+0.68%)
     

  • GOLD FUTURES

    2,350.70
    +8.20 (+0.35%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,660.89
    +376.35 (+2.18%)
     

  • DAX

    18,034.59
    +117.31 (+0.65%)
     

  • CAC 40

    8,065.86
    +49.21 (+0.61%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Allergan CEO resigns from Edwards Lifesciences' board

Reuters - UK Focus

Oct 3 (Reuters) - Edwards Lifesciences Corp (NYSE: EW - news) said David Pyott resigned from the medical device maker's board to devote more time to his role as chairman and CEO of Allergan Inc (NYSE: AGN - news) .

The resignation of Pyott, who joined Edwards' board in 2000, is effective immediately, the company said in a statement.

Allergan is fighting a $53.7-billion hostile bid from Canada's Valeant Pharmaceuticals International Inc (NYSE: VRX - news) and billionaire William Ackman's Pershing Square.

Edwards Lifesciences shares closed at $106.18 Friday on the New York Stock Exchange. (Reporting by Shailesh Kuber in Bangalore; Editing by Anil D'Silva)